TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction April 28, 2006
TCL Archive ‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address January 13, 1995
TCL Archive Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials. May 11, 2001
